Emergent BioSolutions Inc.EBSNYSE
Loading
Net Income ScalingExpanding
Percentile Rank57
5Y CAGR-29.7%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

5Y CAGR
-29.7%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$52.60M+127.6%
2024$-190.60M+74.9%
2023$-760.50M-259.4%
2022$-211.60M-196.4%
2021$219.50M-28.2%
2020$305.80M+461.1%
2019$54.50M-13.1%
2018$62.70M-24.1%
2017$82.60M+59.5%
2016$51.80M-